My story starts in the middle of 2010 when I started having increased frequency in my periods and by November 2010 they had become unbearable with flooding, which was getting to the point of interrupting with my home and work life. My colleagues at work kept losing me and I had to carry a change of clothes with me wherever I went. At this point I went to the GP and asked for a gynaecologist referral, which thankfully because of having a good Dr she agreed to refer me.
Having felt unwell and totally exhausted for about a year, after many tests and a tentative diagnosis of ME, I retired at the age of 61 from a job I loved. This was October 2013. I must have had every test going and the only diagnosis was would I accept ME or CFS as a diagnosis……ugh No! I know that I was not well.
I felt I had to write this after reading so many negative stories about other people’s hysterectomies. I know many women do have a hard time after the op, but not everyone does. Many say it’s the bet thing that happened to them.
I am 50 and had an endometrial ablation 4 years ago for very heavy periods. The specialist removed some uterine polyps at the same time but left a fibroid. The polyps were benign. The ablation stopped all bleeding with my periods so I only knew I was menopausal when I started getting hot flushes 18 months ago and had my hormone levels tested. I started on HRT about 4 months after that (combined estrogen and progesterone).
Hi, I’m very new to all this so don’t really know where to start! I have a condition called Lynch Syndrome or HNPCC. My wonderful mother died 10 years ago at the age of 52 from Endometrial cancer. She previously had Bowel cancer too and at the time a link was not made but we now know she must have has Lynch syndrome too.
Researchers have suggested that women may be able to create some protection for themselves from gynaecological cancers by having their ovaries and uterus removed, if they have been diagnosed with nonpolyposis colorectal cancer or Lynch syndrome.
Endometrial cancer is the most common gynecologic malignancy in the United States. Most women present with a tumor that appears clinically confined to the uterus. Identification of those with metastatic disease allows adjuvant therapy to be appropriately tailored.
Researchers in the Netherlands have recently brought to light worrying evidence of an increased risk of ovarian or womb cancer in women by the ingesting of Acrylamide.
Two studies have produced new evidence which shows that women taking tamoxifen to prevent or treat breast cancer are at a greater risk of suffering from endometrial abnormalities, including cancer.